An Overview Of Cogent Biosciences Inc (NASDAQ: COGT)

In the last trading session, 1.85 million Cogent Biosciences Inc (NASDAQ:COGT) shares changed hands as the company’s beta touched 1.84. With the company’s per share price at $7.42 changed hands at $0.52 or 7.54% during last session, the market valuation stood at $844.82M. COGT’s last price was a discount, traded about -69.95% off its 52-week high of $12.61. The share price had its 52-week low at $3.72, which suggests the last value was 49.87% up since then.

Analysts gave the Cogent Biosciences Inc (COGT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.55. If we narrow down to specifics, the data shows that 0 out of 4 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended COGT as a Hold, 4 felt it is a Buy and 0 rated the stock as Underweight.

Cogent Biosciences Inc (NASDAQ:COGT) trade information

Instantly COGT was in green as seen at the end of in last trading. With action 28.15%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -4.87%, with the 5-day performance at 28.15% in the green. However, in the 30-day time frame, Cogent Biosciences Inc (NASDAQ:COGT) is 54.26% up.

The consensus price target for the stock as assigned by Wall Street analysts is 14, meaning bulls need an upside of 47.0% from its current market value. According to analyst projections, COGT’s forecast low is 14 with 14 as the target high. To hit the forecast high, the stock’s price needs a -88.68% plunge from its current level, while the stock would need to soar -88.68% for it to hit the projected low.

Cogent Biosciences Inc (COGT) estimates and forecasts

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 10.02%. The 2025 estimates are for Cogent Biosciences Inc earnings to increase by 7.71%, but the outlook for the next 5-year period is at 29.82% per year.

Cogent Biosciences Inc (NASDAQ:COGT)’s Major holders

COMMODORE CAPITAL LP holds the second largest percentage of outstanding shares, with 9.8126% or 9.74 million shares worth $82.09 million as of 2024-06-30.

Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Fidelity Securities Fund-Fidelity Small Cap Growth Fund. With 3.29 shares estimated at $24.42 million under it, the former controlled 2.89% of total outstanding shares. On the other hand, Fidelity Securities Fund-Fidelity Small Cap Growth Fund held about 2.27% of the shares, roughly 2.58 shares worth around $19.14 million.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.